| Nov 22 |
Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth
|
| Nov 22 |
MDT Stock Gains From FDA Approval for Its InPen App
|
| Nov 21 |
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
|
| Nov 21 |
HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
|
| Nov 20 |
3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
|
| Nov 20 |
Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?
|
| Nov 20 |
ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System
|
| Nov 19 |
BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
|
| Nov 18 |
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
|
| Nov 18 |
ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to shareholders
|
